Renaissance Technologies LLC reduced its holdings in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) by 40.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 175,300 shares of the company's stock after selling 118,400 shares during the period. Renaissance Technologies LLC owned approximately 0.09% of Aveanna Healthcare worth $801,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also added to or reduced their stakes in the business. KLP Kapitalforvaltning AS acquired a new stake in shares of Aveanna Healthcare in the fourth quarter worth $35,000. Catalyst Funds Management Pty Ltd boosted its stake in shares of Aveanna Healthcare by 321.4% in the fourth quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company's stock worth $54,000 after acquiring an additional 9,000 shares during the last quarter. Arizona State Retirement System acquired a new stake in shares of Aveanna Healthcare in the fourth quarter valued at about $64,000. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Aveanna Healthcare in the fourth quarter valued at approximately $65,000. Finally, EntryPoint Capital LLC purchased a new stake in shares of Aveanna Healthcare in the fourth quarter valued at about $68,000. Institutional investors and hedge funds own 87.96% of the company's stock.
Insiders Place Their Bets
In related news, major shareholder J.H. Whitney Equity Partners V sold 5,580 shares of the business's stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $5.63, for a total value of $31,415.40. Following the completion of the sale, the insider now directly owns 1,451,598 shares in the company, valued at approximately $8,172,496.74. The trade was a 0.38 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have sold 67,412 shares of company stock valued at $372,142 in the last ninety days. Insiders own 7.80% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts have issued reports on the company. Truist Financial cut their target price on Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating on the stock in a research report on Friday, April 11th. UBS Group raised their price objective on shares of Aveanna Healthcare from $3.20 to $4.50 and gave the stock a "sell" rating in a report on Friday, March 14th.
Get Our Latest Stock Report on AVAH
Aveanna Healthcare Stock Up 7.6 %
Shares of Aveanna Healthcare stock traded up $0.34 during trading on Friday, hitting $4.84. 261,120 shares of the company were exchanged, compared to its average volume of 261,042. The stock has a market capitalization of $944.25 million, a price-to-earnings ratio of -14.23 and a beta of 1.99. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $2.29 and a fifty-two week high of $6.19. The firm has a 50 day moving average price of $4.75 and a 200 day moving average price of $4.90.
Aveanna Healthcare Company Profile
(
Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Featured Articles

Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.